JNJ-41443532

DRUG3 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Diabetes Mellitus, Type 2Healthy

Phase 1

JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study

CompletedNCT01105780

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Healthy

Start: 2010-05-31End: 2010-08-31Updated: 2014-04-08

Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants

CompletedNCT01106469

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Healthy

Start: 2010-02-28End: 2010-07-31Updated: 2014-04-08

Phase 2

A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus

CompletedNCT01230749

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Diabetes Mellitus, Type 2

Start: 2010-12-31End: 2011-06-30Updated: 2013-12-11